Merck invests €250 million in Switzerland
Share this article
Merck Biotech Development Center | New Facility in Switzerland
On 27 January 2020, Merck announced a €250 million investment to build a new research and manufacturing facility in Corsier-sur-Vevey, in the canton of Vaud.
The investment, to be made between 2019 and 2022, will help secure the needed facility to develop the biotech R&D and clinical studies manufacturing.